DPP-4 inhibitors suppress cytokine production [14], inhibit monocyte infiltration to tissue niches [36], reduce the disease severity of rheumatoid arthritis in an animal model [16], suppress the inflammatory response in association with multiple sclerosis [47], and suppress the symptoms of inflammatory bowel disease [48]. The gene discussed is DPP4; the disease is inflammatory bowel disease.